Fecal Microbiota Transplantation combined with immune checkpoint inhibitors and Bevacizumab in MSS / pMMR Study on the safety and efficacy of posterior treatment in patients with advanced Colorectal Cancer

ABSTRACT: Interventions: Experimental group:Fecal Microbiota Transplantation combined with Immune Checkpoint Inhibitors and Bevacizumab Primary outcome(s): Changes of intestinal flora quantity;15 immune functions Study Design: Single arm

DISEASE(S): Colorectal Cancer

PROVIDER: 2761742 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR